{
    "nct_id": "NCT03903822",
    "official_title": "A PHASE 2B, RANDOMIZED, DOUBLE BLIND, VEHICLE CONTROLLED, PARALLEL GROUP, DOSE RANGING STUDY TO ASSESS THE EFFICACY, SAFETY, TOLERABILITY AND PHARMACOKINETICS OF PF-06700841 CREAM APPLIED ONCE OR TWICE DAILY FOR 6 WEEKS IN PARTICIPANTS WITH MILD OR MODERATE ATOPIC DERMATITIS",
    "inclusion_criteria": "* Clinical diagnosis of Atopic Dermatitis for at least 3 months\n* Investigator's Global Assessment (IGA) Score of 2 or 3\n* Eczema Area Severity Index (EASI) score of 3-21\n* Body Surface Area (BSA) of 2-20%\n* Peak pruritus-Numerical Rating Scale (PPNRS) of Grade 2 or more\nHealthy volunteers allowed\nMust have minimum age of 12 Years\nMust have maximum age of 75 Years",
    "exclusion_criteria": "* Other forms of dermatological diseases (other than atopic dermatitis)\n* Fitzpatrick skin type score greater than 5\n* Clinically significant abnormal ECG, vital signs, and laboratory values\n* Infection with HBV, HCV, herpes zoster or tuberculosis",
    "miscellaneous_criteria": ""
}